Abstract: Disclosed are a method for changing a game parameter and a client for performing same. The client comprises: a processor for executing a game program; and a transceiver for communicating with a blockchain node of a blockchain network storing a first blockchain, wherein the processor may authenticate a user account and perform a first event of the game program accessed by the user account, the transceiver may transmit, to the blockchain node, a completion signal of the first event including information about the client when the first event is completed and receive, from the blockchain node, a request signal for generating a second event, the processor may generate the second event on the basis of the request signal for generating the second event, and the transceiver may transmit, to the blockchain node, information about the second event.

Abstract: The present application relates to a hybrid cord including a bio-based nylon primarily twisted yarn. According to the present application, while including a primarily twisted yarn including bio-based nylon having a higher modulus compared to chemical-based nylon, there is provided a hybrid cord and has elongation and fatigue resistance equivalent to or higher than commercially required levels (i.e., the level that the cord including a conventional chemical-based nylon primarily twisted yarn has).

Abstract: Disclosed are a method for changing a game parameter and a client for performing same. The client comprises: a processor for executing a game program; and a transceiver for communicating with a blockchain node of a blockchain network storing a first blockchain, wherein the processor may authenticate a user account and perform a first event of the game program accessed by the user account, the transceiver may transmit, to the blockchain node, a completion signal of the first event including information about the client when the first event is completed and receive, from the blockchain node, a request signal for generating a second event, the processor may generate the second event on the basis of the request signal for generating the second event, and the transceiver may transmit, to the blockchain node, information about the second event.

Abstract: A composition for the treatment of atopic dermatitis, the composition including, as an active ingredient, Bifidobacterium animalis subsp. lactis LM1017, and more specifically provided is a composition for the treatment of atopic dermatitis. The composition includes, as an active ingredient, a navel Bifidobacterium animalis subsp. lactis LM1017 which adjusts the NF-?B signal transduction pathway, and thus inhibits the expression of proinflammatory cytokines.

Abstract: The present disclosure relates to a skin whitening cosmetic composition comprising Lactobacillus rhamnosus LM1011 having immunostimulating activity, and more particularly provides a skin whitening cosmetic composition comprising Lactobacillus rhamnosus LM1011, which reduces melanin production by regulating tyrosinase activity, as an active ingredient.

Abstract: Disclosed are a method for changing a game parameter and a client for performing same. The client comprises: a processor for executing a game program; and a transceiver for communicating with a blockchain node of a blockchain network storing a first blockchain, wherein the processor may authenticate a user account and perform a first event of the game program accessed by the user account, the transceiver may transmit, to the blockchain node, a completion signal of the first event including information about the client when the first event is completed and receive, from the blockchain node, a request signal for generating a second event, the processor may generate the second event on the basis of the request signal for generating the second event, and the transceiver may transmit, to the blockchain node, information about the second event.

Abstract: The present disclosure relates to Lactobacillus reuteri LM1071 (KCCM12650P) and a composition containing Lactobacillus reuteri LM1071 for improving the intestinal environment. Lactobacillus reuteri LM1071 (KCCM12650P) according to an embodiment of the present disclosure does not have hemolysis and biogenic amine production capability and has excellent biosafety and excellent intestine adhesion and thus can improve the intestinal environment and improve the intestinal health. Therefore, the strain can be applied to pharmaceutical compositions, food compositions, health functional food compositions, feed compositions, and the like.

Abstract: This application claims the benefit under 35 USC 119(a) of Korean Patent Application No. 10-2017-0162218 filed on Nov. 30, 2016 in the Korean Intellectual Property Office, the entire disclosure of which is incorporated herein by reference for all purposes.